HB 1119 Maryland House of Delegates · 2020 Regular Session

Pharmacists – Required Notification and Authorized Substitution – Lower–Cost Drug or Device Product

Bill status passed 3 of 5 stages cleared

Introduction

Feb 2020

Committee Review

Mar 2020

House of Delegates Passage

Mar 2020

Senate Passage

Governor

Introduced Feb 6, 2020 Last action Mar 16, 2020

Floor votes · House of Delegates Mar 11, 2020

How they voted

92–0

Passed · 8 other

Total votes 100

Mar 11, 2020

D Democratic66

62 Yea 4

93% Yea

R Republican34

30 Yea 4

88% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 15, 2020

Committee

Referred Finance

upper

Mar 14, 2020

Lower · Passed

Third Reading Passed

lower

Mar 13, 2020

Lower · Passed

Favorable with Amendments {

lower

Mar 13, 2020

Lower · Passed

Favorable with Amendments Report by Health and Government Operations

lower

Mar 11, 2020

House Of Delegates · Passed

House of Delegates Vote: pass (92-0-8)

house of delegates

Feb 6, 2020

Committee

First Reading Health and Government Operations

lower

20 primary · 0 co-sponsors